Quality evaluation of the clinical practice guidelines and expert consensus on postmenopausal osteoporosis

XIAO Yao,LIU Ying,WU Hui-yi,ZHONG Jiao,ZHANG Yang

DOI: https://doi.org/10.20043/j.cnki.MPM.202211458

2023-01-01

Abstract:Objective To evaluate the current methodological quality of clinical practice guidelines and expert consensus on postmenopausal osteoporosis（PMOP） by AGREE Ⅱ instrument for providing references for the development of high quality PMOP clinical practice guidelines or expert consensus. Methods Databases including PubMed, WanFang Data, CNKI, VIP, SinoMed and EMbase were searched to collect the clinical practice guidelines or expert consensus on PMOP published from database inception to July 2022, with supplementary searching databases such as Medlive, WHO, NGC and NICE published up to December 2022. Guidelines or expert consensus selection and data extraction were independently performed by two authors. AGREE Ⅱ instrument was used to evaluate the quality of the included guidelines and expert consensus. Intra-class correlation coefficient tests were performed to appraise the uniformity of the overall assessment scores. Results A total of 29 guidelines and expert consensus for PMOP were finally included. The mean scores of six domains were 91%, 52%, 38%, 79%, 37% and 56%. The overall intra-class correlation coefficient was 0.80（P＜0.05）. In terms of editorial independence, foreign guidelines or consensus scores were higher than domestic guidelines or consensus（Z=-2.763, P＜0.05）. The guidelines scored higher than consensus in the field of applicability（Z=-2.387, P＜0.05）. Guidelines and consensus published after 2017 scored higher in the field of stakeholder involvement and clarity of presentation than those before 2017（Z=-2.232, P＜0.05; Z=-3.189, P＜0.05）. Conclusion The quality of the current PMOP clinical practice guidelines and expert consensus is moderate and remains to be improved. In the future, we should strictly follow the development standards of guidelines and formulate guidelines in line with China’s national conditions, so as to provide diagnosis and treatment recommendations for medical staff and corresponding patients in China.